Monsanto is also unlucky, having started developing genetically modified seeds at least twenty years ago.
Later, they created their own genetically modified (GM) database, matrixing all GM seeds in order to find patterns among them.
In preparation for the future ability to customize seed designs.
It's important to know that Monsanto invests at least one billion US dollars in research and development every year, and since 2007, more than half of that one billion US dollars has been invested in genetically modified research and development.
Previously, China did not have to pay Monsanto for any genetically modified agricultural products it produced.
Monsanto holds a large number of core patents related to genetically modified organisms.
However, Monsanto's plan is to wait until genetically modified organisms are widely promoted and become common in China before charging patent fees.
It's the same tactic Microsoft used to tolerate pirated Windows systems in China.
They just didn't expect that the sudden emergence of China Seed Industry Group would shatter Monsanto's dream, and its market share would gradually shrink.
Those who follow the news will know that in 2018, Monsanto was wholly acquired by Bayer Pharmaceuticals and delisted from the US stock market, thus becoming private.
The acquisition cost a staggering 63 billion US dollars, and it even triggered a crisis that led to the layoff of more than 12,000 employees at Bayer Pharmaceuticals. Bayer's market value evaporated by more than 30 billion euros in the following six months.
Everyone knows that Bayer is a German company, but Bayer's largest shareholder is BlackRock, an American asset management giant with assets under management exceeding RMB 50 trillion.
BlackRock was also the investor in the first wholly foreign-owned fund management company to enter China.
Bayer's top ten shareholders include BlackRock, Vanguard Group, Oakmark, and Franklin Resources.
It can be said that nine of Bayer's top ten shareholders are funds under the American financial group.
The only Europa company among the top ten shareholders is the Norwegian government-owned global pension fund.
Therefore, the actual ownership of Bayer Group is in the hands of Wall Street; otherwise, they would not have been able to acquire Monsanto back then.
It seems incredible that America sent a sorcerer to rescue a seed subsidiary of a German pharmaceutical giant.
In fact, this German pharmaceutical company is owned by Amerike.
As a result, Bayer only has the sales rights for this life-extending drug, but not the production rights.
American capital, through the Marshall Plan, directly and indirectly controls too many companies across Europe.
"Personally, I think Monsanto's approach to developing a genetically modified matrix is correct, but the influence of the 'magic' variable is too great."
This caused Monsanto's research and development to fail before it even began, as it was unable to maintain such a high level of research and development due to the overwhelming power of the sorcerers.
Wall Street investors cannot tolerate Monsanto's annual R&D investment exceeding one billion US dollars without any profit in sight.
Unlike Jiang Yan, who devoted himself wholeheartedly to seed research and development, Amerike only sent people to assist Monsanto's seed research part-time.
It merely uses the mage's perception to judge the quality of the seeds after batch processing.
Subsequent seed breeding, screening, and the search for gene mutation points were all completed by Monsanto's R&D personnel.
"The advantages of combining science and magic will become apparent later; the Chinese people's magic seed industry is only at the application stage."
We haven't felt the advantage of being a latecomer for many years.
The mages of America are optimistic.
The main reason is that the technology sector has maintained a leading position for too many years.
The American scientific community rarely doubts its ability to maintain its leading position; most of the questioning is confined to the anti-intellectual atmosphere within America.
And an increasing number of high-achieving students are unwilling to pursue scientific research, instead choosing to study medicine, law, and finance.
The STEM fields are dominated by Indian and Asian students.
Of course, this phenomenon is not unique to America; it exists in universities in Western countries as well, but it is more common in America.
"The tasks assigned to us by the higher-ups are almost impossible to accomplish, and the pharmaceutical companies in Europe share too little information in The Lancet."
It doesn't involve manufacturing processes at all.
Even if we later obtain the life-extending potion and want to reverse-engineer the production process, it will take a lot of time.
It might even be an impossible task.
Reverse engineering is very difficult, especially when technical information is blocked.
China's technological progress in recent years has been due to its own internal factors, as well as the spillover of technology caused by the relocation of overseas supply chains.
Back then, Mr. Hou Debang spent five years reverse-engineering the method of making soda ash, based on the limited information he had on the Sowell process.
Although modern technology and scientific instruments have made progress, the complexity of life-extending drugs has also increased exponentially.
The two had been researching in the field of biomedicine for many years, and after seeing the paper on life-extending drugs in The Lancet, they knew that this task was almost impossible to complete.
Is it possible to obtain production materials from pharmaceutical companies in the European Union or China?
If the other party wants to scale up production, there will definitely be a large number of factories producing it; their secrets cannot be kept.
"The manufacturing process itself will inevitably be leaked sooner or later, but how do we circumvent the other party's patents?"
"We can produce life-extending potions for internal use, as well as optimize existing ones."
They can only extend their lives by one to two years, but we can extend lifespans by much longer.
America is not the only company coveting longevity drugs, but it may be the only one with the capability to continue in-depth research.
This chapter is not finished, please click the next page to continue reading!
Continue read on readnovelmtl.com
